24
Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Embed Size (px)

Citation preview

Page 1: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Tablet EvaluationPharmacopoeial tests (USP)

1- Disintegration2- Dissolution3- Weight uniformity4- Content uniformity5- Friability

Page 2: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

I-DisintegrationThis test is provided to determine whether tablets or capsules disintegrate within the prescribedtime when placed in a liquid medium at the experimental conditions presented below.Compliance with the limits on Disintegration stated in the individual monographs is requiredexcept where the label states that the tablets or capsules are intended for use as troches, orare to be chewed, or are designed as extended-release dosage forms or delayed-releasedosage forms. Determine the type of units under test from the labeling and from observation,and apply the appropriate procedure to 6 or more dosage units

Page 3: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

PROCEDURE• Uncoated Tablets— Place 1 dosage unit in each of the six

tubes of the basket and, if• prescribed, add a disk. Operate the apparatus, using water or

the specified medium as the• immersion fluid, maintained at 37 ± 2 . At the end of the time

limit specified in the• monograph, lift the basket from the fluid, and observe the

tablets: all of the tablets have• disintegrated completely. If 1 or 2 tablets fail to disintegrate

completely, repeat the test on 12• additional tablets. The requirement is met if not fewer than

16 of the total of 18 tablets tested• are disintegrated.

Page 4: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Disintegration apparatus. (All dimensions are expressed in mm.)

Page 5: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

II-DissolutionDefinition-• Dissolution is a process in which a solid substance

solubilizes in a given solvent i.e. mass transfer from the solid surface to the liquid phase.

• Rate of dissolution is the amount of drug substance that goes in solution per unit time under standardized conditions of liquid/solid interface, temperature and solvent composition.

Page 6: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

• The rate of dissolution is given by Noyes and Whitney:

Where,dc/dt= dissolution rate of the drugK= dissolution rate constantCs= concentration of drug in stagnant layer

Cb= concentration of drug in the bulk of the solution at time t

= k (Cs- Cb) dc dt

6

Page 7: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Con

c. o

f di

ssol

ved

drug

Time

first order dissolution under non-sink condition

zero order dissolution under sink condition

Dissolution rate under non-sink and sink conditions.

7

Page 8: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Dissolution test • Introduce the stated volume of the dissolution medium, free from dissolved air, into

the vessel of the apparatus. • Warm the dissolution medium to between 36.5° and 37.5°. Unless otherwise stated

use one tablet or capsule. • When Apparatus I is used, place the tablet or capsule in a dry basket at the beginning

of each test. Lower the basket into position before rotation. • When Apparatus II is used, allow the tablet or capsule to sink to the bottom of the

vessel prior to the rotation of the paddle. A suitable device such as a wire or glass helix is used to keep tablets or capsules that would otherwise float horizontal at the bottom of the vessel.

• Care should be taken to ensure that air bubbles are excluded from the surface of the tablet or capsule.

• Operate the apparatus immediately at the speed of rotation specified in the individual monograph.

• Take samples at the prescribed time. Withdraw the samples from a point half-way between the surface of the dissolution medium and the top of the rotating basket or blade, not less than 10 mm from the wall of the vessel. Add a volume of dissolution medium equal to the volume of the samples withdrawn or compensate by calculation.

• Filter the samples at 36.5° to 37.5° and determine the amount of active ingredient present by the method prescribed in the individual monograph. .

• Repeat the complete operation five times.

Page 9: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Rotating Basket Apparatus (Apparatus 1)

It is basically a closed-compartment, beaker type apparatus.

It comprising of a cylindrical glass vessel with hemispherical bottom of one litre capacity partially immersed in a water bath.

A cylindrical basket made of #22 mesh is located centrally in the vessel at a distance of 2 cm from the bottom and rotated by a variable speed motor through a shaft.

9

Page 10: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Contd…..

All metal parts like basket and shaft are made of stainless steel 316.

Page 11: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Apparatus 1

Page 12: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Rotating Paddle Apparatus (Apparatus 2)

Here, basket is replaced with a stirrer.

A small, loose, wire helix may be attached to the dosage form that would otherwise float.

The position and alignment of the paddle are specified in the official books.

Page 13: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Appratus2

Page 14: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

stage Number

tested

Acceptance criteria

S1 6 Each unit is not less than Q + 5%

S2 6 1- Average of the12 units (S1+ S2) is equal to or greater than Q

2- No unit is less than Q – 15%

S3 12 1. average of the 24units (S1+ S2+ S3) is equal to or greater than Q

2. not more than 2 units are less than Q – 15%3. no unit is less than Q – 25%

Acceptance table

Page 15: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Weight and Hardness Variation:

• Weight and hardness variation are common problems experienced when tableting. Tablet weight is mainly affected by factors such as powder variation, tablet press condition and tooling, and flow of powder on the tablet press.

Page 16: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

• Inconsistent powder or granulate density and particle size distribution are common sources of weight variation during tablet compression. Problems related to the density of the powder or granulate are often associated with overfilling of the die and recirculation of the product on the tablet press. A variation of particle size distribution of the powder or granulate can be the result of segregation due to transfer or static electricity

Page 17: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

• Weight variation can arise as a result of a poorly prepared or operated tablet press.

• Inspection of the critical dimensions of tablet press tools is recommended

• During the course of a compression operation it is also important to not neglect the level of the product in the hopper. Head pressure is a critical factor related to the amount of product in the hopper

Page 18: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

III – uniformity of dosage units

1- Content uniformity test:• it is required for the:Uncoated tablets containing

less than 50 mg of an active ingredient comprising less than 50% of the weight of one dosage unit.

2-Weight variation test:• it is required for the:Uncoated tablets containing

50 mg or more of an active ingredient comprising 50% or more of the weight of one dosage unit.

Page 19: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

1- Content uniformity test• Method• 1- Select not less than 30 units• 2-Assay 10 units individually as directed in the

assay in the individual monograph.• 3- From the assay, calculate the content of active

ingredient in each unit.• 4- Calculate Xi = (content/L.C)*100• 5- Calculate X¯ = ∑ Xi / n ( NO. of tablets tested)• 6- Calculate standard deviation (S) = [(Xi - X¯)2 / (n – 1)]½

• 7- Calculate (Relative standard deviation) RSD = (S / X¯)*100

Page 20: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

2-Weight variation test• Method:• weigh accurately 10 tablets individually• From the assay, calculate the average content % then calculate the

content of active ingredient in each capsule.• Calculate Xi = (content/L.C)*100• Calculate X¯ = ∑ Xi / n ( NO. of tablets tested)• Calculate standard deviation (S) = [(Xi - X¯)2 / (n – 1)]½

• Calculate RSD ( Relative standard deviation) = ( S / X¯)*100

Page 21: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Criteria:• Accepted if: • the amount of Xi of the 10 tablets lies within the range of 85% to

115% • And RSD of the 10 tablets is less than or equal to 6%.• Suspected if:• One Xi is outside the range 85% to 115% but not outside the range

of 75% to 125%.• Or RSD is greater than 6%• Or both conditions. Test 20 another 20 tablets• Accepted if:

– Not more than one Xi of 30 Xi are outside the range of 85% to 115% – None outside the range of 75% to 125%.– RSD of the 30 tablets is less than or equal to 7.8 %.

Page 22: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

IV- Friability (measure of tablet resistance to abrasion)

Page 23: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

Reasons of tablet friability

• Hardness variation• Capping and lamination• Low moisture content in tablets• Low binder efficiency

Page 24: Tablet Evaluation Pharmacopoeial tests (USP) 1- Disintegration 2- Dissolution 3- Weight uniformity 4- Content uniformity 5- Friability

• For tablets with a unit weight equal to or less than 650 mg, take a sample of whole tablets corresponding as near as possible to 6.5 g. For tablets with a unit weight of more than 650 mg,take a sample of 10 whole tablets. The tablets should be carefully dedusted prior to testing.

• Accurately weigh the tablet sample, and place the tablets in the drum. Rotate the drum 100 times, and remove the tablets. Remove any loose dust from the tablets as before, and accurately weigh.

• Generally, the test is run once. If obviously cracked, cleaved, or broken tablets are present in the tablet sample after tumbling, the sample fails the test. If the results are difficult to interpret or if the weight loss is greater than the targeted value, the test should be repeated twice and the mean of the three tests determined. A maximum mean weight loss from the three samples of not more than 1.0% is considered acceptable for most products